CVS Caremark (CVS) Reports In-Line Q4 EPS; Boosts Q112 EPS, Guides FY12 EPS
CVS Hot Sheet
Revenue Growth %: +18.9%Financial Fact:
Operating profit: 1.4B
Today's EPS Names:
TARO, BRLI, TLB, More
CVS Caremark (NYSE: CVS) reported Q4 EPS of $0.89, in-line with the analyst estimate of $0.89. Revenue for the quarter came in at $28.3 billion versus the consensus estimate of $28.12 billion.
CVS Caremark sees FY2012 EPS of $3.18-$3.28, versus the consensus of $3.24.
CVS Caremark sees Q1 2012 EPS of $0.61-$0.63, versus prior guidance of $0.58-$0.60 and the consensus of $0.61.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
CVS Caremark sees FY2012 EPS of $3.18-$3.28, versus the consensus of $3.24.
CVS Caremark sees Q1 2012 EPS of $0.61-$0.63, versus prior guidance of $0.58-$0.60 and the consensus of $0.61.
For earnings history and earnings-related data on CVS Caremark (CVS) click here.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Infoblox (BLOX) Tops Q3 EPS by 4c; Guides Q4
- Pandora (P) Blows Up Expectations as Listener Hours Rip; Guides FY13 Ahead of Views
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
